Hebei Changshan Biochemical Pharmaceutical announced that Chairman and General Manager Gao Xiaodong has resigned from the general manager position due to work adjustments. He will continue to serve as Chairman and Chairman of the Strategy Committee. His original term was set to run until December 26, 2027. The resignation report took effect upon delivery to the board of directors. As of the announcement date, he holds 1,530,000 shares in the company. To ensure daily operations and management, the company's sixth board of directors approved at its ninth meeting to authorize Deputy General Manager Chang Yanlu to perform the duties of general manager, effective from the date of board approval until a new general manager is appointed. Chang Yanlu was born in 1983, holds a postgraduate degree, and is a senior auditor, certified public accountant, and certified tax agent. He previously served as Financial Audit Director in the Audit Department of Shougang Group. He joined the company in August 2021 and has served as Deputy General Manager since December 2024. He does not hold company shares and has no related-party relationship with the controlling shareholder or shareholders holding more than 5 percent of shares.
Hebei Changshan Biochem PharmaGeneral manager resigns but remains chairman; deputy GM Chang Yanlu takes over duties, a leadership change with no clear positive or negative driver.
